Stop Risky Ads: Class Actions Could Cost You
DarshanTalks Podcast
English - May 13, 2024 13:00 - 22 minutes - 15.8 MB - ★★★★★ - 1 ratingNews pharma medical devices fda laws regulations guidances clinical research advertising mergers acquisitions Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Legal Minute: How do drugs work?
In this podcast, we discuss the following:
Recent updates from the courts in class action lawsuits. Difference between equity and law. Demerging or diverging equity and law. Dictionaries used by courts to interpret contracts. Update on Johnson and Johnson baby powder case (Suing plaintiff’s witnesses for defamation and false advertising) Experts need to be cautious to avoid false advertising allegations against them. Update on Maybelline 24-hour make-up case. (24-hour sunscreen) Rebecca Tushnet is our guest. She is a Harvard Law School professor specializing in copyright, trademark, and advertising law.
Let’s get into it.